INNOTESTO BVBA has a total of 27 patent applications. Its first patent ever was published in 2011. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, medical technology and micro-structure and nano-technology are BERGTER WOLFGANG, BIODELIVERY SCIENCES INT INC and DELEX THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 6 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Canada | 3 | |
#5 | United Kingdom | 3 | |
#6 | Australia | 2 | |
#7 | Brazil | 2 | |
#8 | China | 2 | |
#9 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology | |
#3 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Syringes | |
#4 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Merkus Franciscus Wilhelmus Henricus Maria | 22 |
#2 | Merkus Bart | 5 |
#3 | Franciscus Wilhelmus Henricus Maria Merkus | 2 |
Publication | Filing date | Title |
---|---|---|
GB202013645D0 | Pharmacetical compositions for the nasal administration of a colbalamin compound | |
EP3062770A1 | Nasal compositions stimulating ciliary activity | |
GB201217419D0 | Improvements in or relating to oromucosal apomorphine compositions | |
GB201200062D0 | Estradiol oromucosal liquid compositions | |
AU2011291075A1 | Testosterone solutions for the treatment of testosterone deficiency |